Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
4.020
-0.100 (-2.43%)
At close: Jun 30, 2025, 4:00 PM
3.960
-0.060 (-1.49%)
After-hours: Jun 30, 2025, 5:14 PM EDT
Lexeo Therapeutics Market Cap
Lexeo Therapeutics has a market cap or net worth of $217.07 million as of June 30, 2025. Its market cap has decreased by -62.52% in one year.
Market Cap
217.07M
Enterprise Value
125.98M
1-Year Change
-62.52%
Ranking
Category
Stock Price
$4.02
Market Cap Chart
Since the IPO on November 3, 2023, Lexeo Therapeutics's market cap has decreased from $271.36M to $217.07M, a decrease of -20.01%. That is a compound annual growth rate of -12.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 222.47M | 2.21% |
| Dec 31, 2024 | 217.65M | -39.13% |
| Dec 29, 2023 | 357.58M | 31.78% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| AbbVie | 322.03B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.41B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 217.42B |